U.S. Markets open in 5 hrs 44 mins

Laboratory Corporation of America Holdings (LH)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
150.30-2.00 (-1.31%)
At close: 4:02PM EDT
People also watch
DGXHUMMCKPDCOWAT
  • LH reached a new Ten Year High at 148.23
  • Forgive your enemies, but never forget their names. http://dataunion.tistory.com/12946

    Laboratory Corp_ of America Ho NYSE $LH Correlation Histogram
    X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks Sep-2016 1,000 Day Parameter 4,338 NYSE Stocks Price Analysis This stock mode of correlation coefficient is -0.8 In other words, the correlation coefficient of the other stocks
    dataunion.tistory.com
  • LH-said its earnings and sales rose in the most recent quarter.

    The company also gave an upbeat 2017 outlook, forecasting adjusted earnings of $9.35 to $9.75 on revenue growth of 4.5% to 6.5%. Analysts polled by Thomson Reuters were expecting $9.63 on 4.4% revenue growth.

    In all for the fourth quarter Laboratory Corp. reported a profit of $184.4 million, or $1.75 a share, up from $110 million, or $1.07, a year earlier. Excluding certain items, earnings rose to $2.15 from $1.98 cents. Revenue grew 6.3% to $2.39 billion.
  • 1/23/17-Laboratory Corporation Price Target Announced at $170.00/Share by Deutsche Bank
  • Last SPLIT was 2002 (2 for 1) -STILL ONLY 100Million Shares outstanding.
    IMHO_ IF another SPLIT is announced-it could be around Dec. 9th--which would be ex-div. date (if Div. was forthcoming)
    IMHO- Theranos Departure from Lab Diagnostics-has helped LH icrease Market Share....
  • Info for $LH on http://otc.report/?s=LH

  • S&P Capital NEW LH PRICE TARGET: 12-month target of $155, 15.8X our '17 EPS estimate.
    This multiple is a premium to peers, justified by our above average sales growth outlook.
    ***We raise our '16 and '17 EPS estimates by $0.02 and $0.10 to $8.81 and $9.79.
    LH reported Q3 operating EPS of $2.25 vs $2.07, $0.04. Q3 sales increased 4.5%.
    We expect 10.8% sales growth in '16 aided by pricing improvements due to growth in esoteric test volumes.
  • Laboratory Corporation of America® Holdings (LabCorp®) (LH) today announced it will participate at the 2016 Credit Suisse Nov-7th-Healthcare Conference.
    LabCorp’s presentation is planned for Monday, November 7, 2016 at 12:30 PM (ET).
  • Info for $LH on http://otc.report/?s=LH

  • IMHO, the recent drop to the $124 level just offered an opportunity for a long term BUY. They are growing fast and I don't think they will be this cheap again.
  • As investors are you at all concerned with the terrible back office at LCA? I've been fighting them through my insurance company for six months on a service that was paid back in January. Labcorp was paid on April 26, 2016 by my insurance but I continue to be billed, in full, for the service. I call my insurance, they confirm payment, then call Labcorp. Labcorp says they will put my billing on hold and will look into it. Then a couple of months later without comment from Labcorp I get another ever escalating invoice/collection notice. This is extremely poor customer service. It seems like my only recourse is to hire an attorney that I can not afford. Maybe there are others out there with the same problem. If so we could start a class action against LCA.
  • Demise of Theranos no great surprise, but removes a potential long term negative.
  • With Theranos OUT--there is LESS Competition!
  • http://dataunion.tistory.com/6329

    MAY-2016 Laboratory Corp_ of America Holdings NYSE : LH Correlation Histogram
    X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks May-2016 1,000 Day Parameter 4,338 NYSE Stocks Price Analysis This stock mode of correlation coefficient is -0.8 In other words, the correlation coefficient of the other stocks
    dataunion.tistory.com